XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Statements of Operations and Comprehensive Loss - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Costs and expenses:        
Research and development expense $ 6,285,734 $ 4,072,708 $ 12,311,195 $ 9,491,414
General and administrative expense 4,071,960 4,857,237 9,161,526 10,379,549
Total costs and expenses 10,357,694 8,929,945 21,472,721 19,870,963
Loss from operations (10,357,694) (8,929,945) (21,472,721) (19,870,963)
Interest income 262,288 671,033 640,648 1,252,701
Net loss and comprehensive loss $ (10,095,406) $ (8,258,912) $ (20,832,073) $ (18,618,262)
Basic net loss per common share (in dollars per share) $ (0.16) $ (0.13) $ (0.32) $ (0.30)
Diluted net loss per common share (in dollars per share) $ (0.16) $ (0.13) $ (0.32) $ (0.30)
Basic weighted-average number of common shares outstanding (in shares) 64,483,848 64,276,184 64,470,541 62,313,155
Diluted weighted-average number of common shares outstanding (in shares) 64,483,848 64,276,184 64,470,541 62,313,155